Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | FLT1 | P17948 | 1/20 | 0.48 |
| ▸ | FLT4 | P35916 | 1/20 | 0.48 |
| ▸ | KDR | P35968 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15258016 | 0.89 | HPGD (0.47) | ALDH1A1MAPTKDM4ELMNAL3MBTL1 | |
| SCHEMBL4924405 | 0.81 | ALDH1A1 (0.55) | ALDH1A1MAPTKDM4ELMNAL3MBTL1 | |
| SCHEMBL4588477 | 0.81 | ALDH1A1 (0.55) | ALDH1A1MAPTKDM4ELMNAL3MBTL1 | |
| SCHEMBL27610435 | 0.81 | ALDH1A1 (0.55) | ALDH1A1MAPTKDM4ELMNAL3MBTL1 | |
| SCHEMBL27668460 | 0.78 | LMNA (0.55) | ALDH1A1MAPTKDM4ELMNAL3MBTL1 | |
| SCHEMBL12514716 | 0.78 | ALDH1A1 (0.56) | ALDH1A1MAPTKDM4ERAB9ASMN1; SMN2 | |
| SCHEMBL10038575 | 0.78 | OGG1 (0.57) | ALDH1A1MAPTKDM4EL3MBTL1CES2 | |
| SCHEMBL28339402 | 0.78 | HPGD (0.63) | ALDH1A1LMNACES2CES1POLB | |
| SCHEMBL6744163 | 0.78 | MEN1 (0.52) | CES2CES1POLBRAB9ASMN1; SMN2 | |
| SCHEMBL28311338 | 0.78 | ALDH1A1 (0.57) | ALDH1A1MAPTKDM4ELMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115524417-B | Analysis method of rebamipide tablet related substances and isomers | 杭州沐源生物医药科技有限公司 | 2023-05-26 | — | — | CN | claimed |
| CN-115524417-A | Analysis method of related substances and isomers of rebamipide tablets | 杭州沐源生物医药科技有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-112816585-B | Method for detecting rebamipide and related substances thereof | 苏州正济药业有限公司 | 2022-09-27 | — | — | CN | claimed |
| CN-112816585-A | Method for detecting rebamipide and related substances thereof | 苏州正济药业有限公司 | 2021-05-18 | — | — | CN | claimed |
| CN-115524417-B | Analysis method of rebamipide tablet related substances and isomers | 杭州沐源生物医药科技有限公司 | 2023-05-26 | — | — | CN | disclosed |
| CN-115524417-A | Analysis method of related substances and isomers of rebamipide tablets | 杭州沐源生物医药科技有限公司 | 2022-12-27 | — | — | CN | disclosed |
| CN-112816585-B | Method for detecting rebamipide and related substances thereof | 苏州正济药业有限公司 | 2022-09-27 | — | — | CN | disclosed |
| CN-112816585-A | Method for detecting rebamipide and related substances thereof | 苏州正济药业有限公司 | 2021-05-18 | — | — | CN | disclosed |
| US-20090042864-A2 | PYRAZOLE COMPOUNDS | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2009-02-12 | — | — | US | disclosed |
| US-20080261286-A1 | Methods for producing optically active alpha-hydroxy amides | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2008-10-23 | — | — | US | disclosed |
| US-20050202545-A1 | Methods for producing optically active alpha-hydroxy amides | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2005-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042864-A2 | PYRAZOLE COMPOUNDS | CNR2, CNR1, GPR18 | ALDH1A1 1456/4885MAPT 1094/4885KDM4E 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.